SEARCH

SEARCH BY CITATION

References

  • Baulac M, Pitkanen A. (2009) Research priorities in epilepsy for the next decade-a representative view of the European scientific community. Epilepsia 50:571578.
  • Blamire AM, Anthony DC, Rajagopalan B, Sibson NR, Perry VH, Styles P. (2000) Interleukin-1beta -induced changes in blood–brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study. J Neurosci 20:81538159.
  • Buckmaster PS, Lew FH. (2011) Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy. J Neurosci 31:23372347.
  • Buckmaster PS, Ingram EA, Wen X. (2009) Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy. J Neurosci 29:82598269.
  • Chauhan A, Sharma U, Jagannathan NR, Reeta KH, Gupta YK. (2011) Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats. Behav Brain Res 225:603609.
  • Cornford EM, Oldendorf WH. (1986) Epilepsy and the bloodbrain barrier. Adv Neurol 44:787812.
  • Daoud D, Scheld HH, Speckmann EJ, Gorji A. (2007) Rapamycin: brain excitability studied in vitro. Epilepsia 48:834836.
  • Dichter MA. (2009) Emerging concepts in the pathogenesis of epilepsy and epileptogenesis. Arch Neurol 66:443447.
  • Erlich S, Alexandrovich A, Shohami E, Pinkas-Kramarski R. (2007) Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis 26:8693.
  • Fabene PF, Navarro MG, Martinello M, Rossi B, Merigo F, Ottoboni L, Bach S, Angiari S, Benati D, Chakir A, Zanetti L, Schio F, Osculati A, Marzola P, Nicolato E, Homeister JW, Xia L, Lowe JB, McEver RP, Osculati F, Sbarbati A, Butcher EC, Constantin G. (2008) A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 14:13771383.
  • Gorter JA, Van Vliet EA, Aronica E, Lopes da Silva FH. (2001) Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin-immunoreactive neurons. Eur J Neurosci 13:657669.
  • Huang X, Zhang H, Yang J, Wu J, McMahon J, Lin Y, Cao Z, Gruenthal M, Huang Y. (2010) Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy. Neurobiol Dis 40:193199.
  • Kelley MS, Jacobs MP, Lowenstein DH. (2009) The NINDS epilepsy research benchmarks. Epilepsia 50:579582.
  • Lassmann H, Petsche U, Kitz K, Baran H, Sperk G, Seitelberger F, Hornykiewicz O. (1984) The role of brain edema in epileptic brain damage induced by systemic kainic acid injection. Neuroscience 13:691704.
  • Ljungberg MC, Bhattacharjee MB, Lu Y, Armstrong DL, Yoshor D, Swann JW, Sheldon M, D’Arcangelo G. (2006) Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia. Ann Neurol 60:420429.
  • Lorenzo AV, Shirahige I, Liang M, Barlow CF. (1972) Temporary alteration of cerebrovascular permeability to plasma protein during drug-induced seizures. Am J Physiol 223:268277.
  • Loscher W, Brandt C. (2010) Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev 62:668700.
  • Marchi N, Angelov L, Masaryk T, Fazio V, Granata T, Hernandez N, Hallene K, Diglaw T, Franic L, Najm I, Janigro D. (2007) Seizure-promoting effect of bloodbrain barrier disruption. Epilepsia 48:732742.
  • Marchi N, Granata T, Freri E, Ciusani E, Ragona F, Puvenna V, Teng Q, Alexopolous A, Janigro D. (2011a) Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. PLoS ONE 6:e18200.
  • Marchi N, Tierney W, Alexopoulos AV, Puvenna V, Granata T, Janigro D. (2011b) The etiological role of bloodbrain barrier dysfunction in seizure disorders. Cardiovasc Psychiatry Neurol 2011:482415.
  • Martin-Martin N, Ryan G, McMorrow T, Ryan MP. (2010) Sirolimus and cyclosporine A alter barrier function in renal proximal tubular cells through stimulation of ERK1/2 signaling and claudin-1 expression. Am J Physiol Renal Physiol 298:F672F682.
  • Oby E, Janigro D. (2006) The bloodbrain barrier and epilepsy. Epilepsia 47:17611774.
  • Paxinos G, Watson C. (1998) The rat brain in stereotaxic coordinates. Academic press, San Diego, CA.
  • Rigau V, Morin M, Rousset MC, de Bock F, Lebrun A, Coubes P, Picot MC, Baldy-Moulinier M, Bockaert J, Crespel A, Lerner-Natoli M. (2007) Angiogenesis is associated with bloodbrain barrier permeability in temporal lobe epilepsy. Brain 130:19421956.
  • Ruegg S, Baybis M, Juul H, Dichter M, Crino PB. (2007) Effects of rapamycin on gene expression, morphology, and electrophysiological properties of rat hippocampal neurons. Epilepsy Res 77:8592.
  • Seiffert E, Dreier JP, Ivens S, Bechmann I, Tomkins O, Heinemann U, Friedman A. (2004) Lasting bloodbrain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci 24:78297836.
  • Shlosberg D, Benifla M, Kaufer D, Friedman A. (2010) Bloodbrain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 6:393403.
  • Shorvon S, Ferlisi M. (2011) The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 134:28022818.
  • Sliwa A, Plucinska G, Bednarczyk J, Lukasiuk K. (2012) Post-treatment with rapamycin does not prevent epileptogenesis in the amygdala stimulation model of temporal lobe epilepsy. Neurosci Lett 509:105109.
  • van Vliet EA, da Costa Araujo S, Redeker S, van Schaik R, Aronica E, Gorter JA. (2007) Bloodbrain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 130:521534.
  • Vezzani A, French J, Bartfai T, Baram TZ. (2011) The role of inflammation in epilepsy. Nat Rev Neurol 7:3140.
  • Wong M. (2010) Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies. Epilepsia 51:2736.
  • Zeng LH, Xu L, Gutmann DH, Wong M. (2008) Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 63:444453.
  • Zeng LH, Rensing NR, Wong M. (2009a) Developing antiepileptogenic drugs for acquired epilepsy: targeting the mammalian target of rapamycin (mTOR) pathway. Mol Cell Pharmacol 1:124129.
  • Zeng LH, Rensing NR, Wong M. (2009b) The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci 29:69646972.
  • Zucker DK, Wooten GF, Lothman EW. (1983) Bloodbrain barrier changes with kainic acid-induced limbic seizures. Exp Neurol 79:422433.